{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:26:00Z","timestamp":1783023960325,"version":"3.54.6"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    A 66-year-old man with a history of prostate adenocarcinoma treated with radiotherapy and endocrine therapy underwent\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA PET\/CT. Both scans showed marked radiotracer uptake, raising suspicion for disease recurrence. However, subsequent transurethral resection of the prostate was performed for treatment with concurrent pathologic biopsy, confirmed only chronic inflammation accompanied by focal necrosis and calcification, emphasizing the false-positive risk of these modalities in nonmalignant conditions.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006416","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:00:19Z","timestamp":1775487619000},"page":"674-676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Severe Post-treatment Calcification for Prostate Cancer With Dual \u00b9\u2078F-FDG and \u2076\u2078Ga-PSMA Avidity on PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Bulin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00259-023-06585-7","article-title":"Combination of [18F]FDG and [18F]PSMA-1007 PET\/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer","volume":"51","author":"Kim","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1007\/s00259-021-05221-6","article-title":"Diagnostic value of 18F-FDG PET\/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET\/CT","volume":"48","author":"Chen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20260702","article-title":"18F-PSMA expression in amoebic liver abscesses mimics as metastatic prostate cancer","author":"Meena","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/RLU.0000000000003290","article-title":"Avid 68Ga-PSMA uptake in periappendicular abscess","volume":"45","author":"Christensen","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/RLU.0000000000006153","article-title":"High-grade 18F-PSMA-1007 uptake of benign prostatic hyperplasia with chronic inflammation","volume":"51","author":"Man","year":"2026","journal-title":"Clin Nucl Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1007\/s00259-025-07148-8","article-title":"Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: a radio-pathology matching analysis","volume":"52","author":"Li","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"728.e1","DOI":"10.1016\/j.urolonc.2020.12.028","article-title":"Prostatic calcifications: quantifying occurrence, radiodensity, and spatial distribution in prostate cancer patients","volume":"39","author":"Singh","year":"2021","journal-title":"Urol Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:03:49Z","timestamp":1783022629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006416","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"2026-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}